Logo image of CDRE

CADRE HOLDINGS INC (CDRE) Stock Fundamental Analysis

NYSE:CDRE - New York Stock Exchange, Inc. - US12763L1052 - Common Stock - Currency: USD

33.45  +0.68 (+2.08%)

After market: 33.45 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CDRE. CDRE was compared to 66 industry peers in the Aerospace & Defense industry. While CDRE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CDRE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year CDRE was profitable.
In the past year CDRE had a positive cash flow from operations.
CDRE had positive earnings in each of the past 5 years.
In the past 5 years CDRE always reported a positive cash flow from operatings.
CDRE Yearly Net Income VS EBIT VS OCF VS FCFCDRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

CDRE has a Return On Assets of 5.86%. This is in the better half of the industry: CDRE outperforms 74.24% of its industry peers.
CDRE has a better Return On Equity (12.11%) than 78.79% of its industry peers.
With a decent Return On Invested Capital value of 8.93%, CDRE is doing good in the industry, outperforming 77.27% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CDRE is in line with the industry average of 8.44%.
The 3 year average ROIC (8.67%) for CDRE is below the current ROIC(8.93%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.86%
ROE 12.11%
ROIC 8.93%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
CDRE Yearly ROA, ROE, ROICCDRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 200 300 400

1.3 Margins

Looking at the Profit Margin, with a value of 6.87%, CDRE is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CDRE's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 12.85%, CDRE belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
CDRE's Operating Margin has improved in the last couple of years.
CDRE has a better Gross Margin (41.44%) than 84.85% of its industry peers.
In the last couple of years the Gross Margin of CDRE has grown nicely.
Industry RankSector Rank
OM 12.85%
PM (TTM) 6.87%
GM 41.44%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
CDRE Yearly Profit, Operating, Gross MarginsCDRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CDRE is destroying value.
CDRE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CDRE has been increased compared to 5 years ago.
CDRE has a worse debt/assets ratio than last year.
CDRE Yearly Shares OutstandingCDRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CDRE Yearly Total Debt VS Total AssetsCDRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 4.04 indicates that CDRE is not in any danger for bankruptcy at the moment.
CDRE has a Altman-Z score (4.04) which is in line with its industry peers.
CDRE has a debt to FCF ratio of 5.33. This is a neutral value as CDRE would need 5.33 years to pay back of all of its debts.
The Debt to FCF ratio of CDRE (5.33) is better than 69.70% of its industry peers.
CDRE has a Debt/Equity ratio of 0.66. This is a neutral value indicating CDRE is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.66, CDRE is not doing good in the industry: 60.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.33
Altman-Z 4.04
ROIC/WACC0.84
WACC10.57%
CDRE Yearly LT Debt VS Equity VS FCFCDRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CDRE has a Current Ratio of 3.55. This indicates that CDRE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.55, CDRE is in the better half of the industry, outperforming 78.79% of the companies in the same industry.
A Quick Ratio of 2.57 indicates that CDRE has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.57, CDRE is doing good in the industry, outperforming 78.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.55
Quick Ratio 2.57
CDRE Yearly Current Assets VS Current LiabilitesCDRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

CDRE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.94%.
Measured over the past years, CDRE shows a very strong growth in Earnings Per Share. The EPS has been growing by 34.28% on average per year.
CDRE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.06%.
CDRE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.17% yearly.
EPS 1Y (TTM)-5.94%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%27.78%
Revenue 1Y (TTM)10.06%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%-5.62%

3.2 Future

Based on estimates for the next years, CDRE will show a very strong growth in Earnings Per Share. The EPS will grow by 20.01% on average per year.
CDRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.62% yearly.
EPS Next Y40.37%
EPS Next 2Y27.81%
EPS Next 3Y20.01%
EPS Next 5YN/A
Revenue Next Year12.09%
Revenue Next 2Y10.01%
Revenue Next 3Y1.62%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CDRE Yearly Revenue VS EstimatesCDRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CDRE Yearly EPS VS EstimatesCDRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 35.21 indicates a quite expensive valuation of CDRE.
Based on the Price/Earnings ratio, CDRE is valued a bit cheaper than 68.18% of the companies in the same industry.
CDRE is valuated rather expensively when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 22.75, which indicates a rather expensive current valuation of CDRE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CDRE indicates a somewhat cheap valuation: CDRE is cheaper than 71.21% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CDRE to the average of the S&P500 Index (35.19), we can say CDRE is valued slightly cheaper.
Industry RankSector Rank
PE 35.21
Fwd PE 22.75
CDRE Price Earnings VS Forward Price EarningsCDRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

75.76% of the companies in the same industry are more expensive than CDRE, based on the Enterprise Value to EBITDA ratio.
CDRE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CDRE is cheaper than 81.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.85
EV/EBITDA 16.08
CDRE Per share dataCDRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

CDRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of CDRE may justify a higher PE ratio.
CDRE's earnings are expected to grow with 20.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.87
PEG (5Y)N/A
EPS Next 2Y27.81%
EPS Next 3Y20.01%

More info and screens

4

5. Dividend

5.1 Amount

CDRE has a Yearly Dividend Yield of 1.16%. Purely for dividend investing, there may be better candidates out there.
CDRE's Dividend Yield is rather good when compared to the industry average which is at 1.20. CDRE pays more dividend than 87.88% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, CDRE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.16%

5.2 History

CDRE has been paying a dividend for over 5 years, so it has already some track record.
CDRE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
CDRE Yearly Dividends per shareCDRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

CDRE pays out 37.76% of its income as dividend. This is a sustainable payout ratio.
DP37.76%
EPS Next 2Y27.81%
EPS Next 3Y20.01%
CDRE Yearly Income VS Free CF VS DividendCDRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 20M 40M 60M
CDRE Dividend Payout.CDRE Dividend Payout, showing the Payout Ratio.CDRE Dividend Payout.PayoutRetained Earnings

More info and screens

CADRE HOLDINGS INC

NYSE:CDRE (7/14/2025, 4:10:03 PM)

After market: 33.45 0 (0%)

33.45

+0.68 (+2.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners70.01%
Inst Owner Change0%
Ins Owners30.6%
Ins Owner Change0.15%
Market Cap1.36B
Analysts80
Price Target43.52 (30.1%)
Short Float %6.16%
Short Ratio5.24
Dividend
Industry RankSector Rank
Dividend Yield 1.16%
Yearly Dividend0.36
Dividend Growth(5Y)N/A
DP37.76%
Div Incr Years1
Div Non Decr Years3
Ex-Date05-02 2025-05-02 (0.095)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.05%
Min EPS beat(2)-31.8%
Max EPS beat(2)87.91%
EPS beat(4)3
Avg EPS beat(4)28.09%
Min EPS beat(4)-31.8%
Max EPS beat(4)87.91%
EPS beat(8)6
Avg EPS beat(8)27.15%
EPS beat(12)7
Avg EPS beat(12)11.71%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.72%
Min Revenue beat(2)0.97%
Max Revenue beat(2)4.48%
Revenue beat(4)2
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-15.05%
Max Revenue beat(4)4.48%
Revenue beat(8)6
Avg Revenue beat(8)0.54%
Revenue beat(12)9
Avg Revenue beat(12)1.09%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.66%
PT rev (3m)1.11%
EPS NQ rev (1m)0.36%
EPS NQ rev (3m)-19.5%
EPS NY rev (1m)-0.52%
EPS NY rev (3m)-1.03%
Revenue NQ rev (1m)-0.92%
Revenue NQ rev (3m)1.52%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)4.73%
Valuation
Industry RankSector Rank
PE 35.21
Fwd PE 22.75
P/S 2.43
P/FCF 32.85
P/OCF 28.92
P/B 4.28
P/tB 21.57
EV/EBITDA 16.08
EPS(TTM)0.95
EY2.84%
EPS(NY)1.47
Fwd EY4.4%
FCF(TTM)1.02
FCFY3.04%
OCF(TTM)1.16
OCFY3.46%
SpS13.77
BVpS7.81
TBVpS1.55
PEG (NY)0.87
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.86%
ROE 12.11%
ROCE 12.79%
ROIC 8.93%
ROICexc 11.71%
ROICexgc 28.76%
OM 12.85%
PM (TTM) 6.87%
GM 41.44%
FCFM 7.39%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
ROICexc(3y)11.24%
ROICexc(5y)14.1%
ROICexgc(3y)24.24%
ROICexgc(5y)30.41%
ROCE(3y)12.41%
ROCE(5y)17.14%
ROICexcg growth 3Y-11.18%
ROICexcg growth 5Y5.68%
ROICexc growth 3Y-14.82%
ROICexc growth 5Y2.49%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
F-Score6
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.33
Debt/EBITDA 2.37
Cap/Depr 34.49%
Cap/Sales 1.01%
Interest Coverage 4.65
Cash Conversion 53.27%
Profit Quality 107.66%
Current Ratio 3.55
Quick Ratio 2.57
Altman-Z 4.04
F-Score6
WACC10.57%
ROIC/WACC0.84
Cap/Depr(3y)35.32%
Cap/Depr(5y)31.71%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.04%
Profit Quality(3y)322.36%
Profit Quality(5y)273.24%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.94%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%27.78%
EPS Next Y40.37%
EPS Next 2Y27.81%
EPS Next 3Y20.01%
EPS Next 5YN/A
Revenue 1Y (TTM)10.06%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%-5.62%
Revenue Next Year12.09%
Revenue Next 2Y10.01%
Revenue Next 3Y1.62%
Revenue Next 5YN/A
EBIT growth 1Y15.12%
EBIT growth 3Y9.65%
EBIT growth 5Y15.18%
EBIT Next Year77.33%
EBIT Next 3Y30.01%
EBIT Next 5YN/A
FCF growth 1Y-9.79%
FCF growth 3Y-11.18%
FCF growth 5Y43.24%
OCF growth 1Y-6.33%
OCF growth 3Y-7.45%
OCF growth 5Y33.8%